Fisetin and Alzheimer's Disease: What the Clinical Data Shows

Evidence correction: Fisetin is not a proven Alzheimer’s prevention or treatment. Do not delay evaluation of memory symptoms.

Expert Summary

Fisetin crosses the blood-brain barrier and reduces neuroinflammation, tau hyperphosphorylation, and amyloid-beta plaque formation in multiple Alzheimer's disease animal models. The Alzheimer's Research Association-funded MEND-AD trial is currently evaluating fisetin in human subjects with mild cognitive impairment.

Key Facts

As an Amazon Associate, Stacking Years earns from qualifying purchases.

Life Extension Bio-Fisetin

8 mg fisetin per capsule

Low-dose fisetin with fenugreek galactomannans.

Best for: reviewing a low-dose fisetin label in Key Facts

View on Amazon · Affiliate link

Frequently Asked Questions

Can fisetin prevent Alzheimer's disease?

Current evidence is preclinical. Fisetin cannot be claimed to prevent or treat Alzheimer's. However, its multi-target mechanisms (senolytic, anti-tau, anti-amyloid, anti-inflammatory) make it a promising preventive candidate in high-risk populations.

What dose is used for brain health?

For neuroprotection, lower continuous doses (100–200 mg/day) are used by some practitioners in addition to periodic burst dosing (20 mg/kg, 2 days). Human trial data for specific neuroprotective doses is still emerging.

Should people with Alzheimer's family history take fisetin?

Given its safety profile and multi-mechanism brain protection, many longevity practitioners recommend fisetin for those with APOE4 genotype or Alzheimer's family history. This is an individual decision best made with a healthcare provider.

Scientific References

Alzheimer’s evidence is preclinical or still being tested

Fisetin has been studied in cells and animal models for effects on inflammation, oxidative stress, and pathways related to neuronal function. These experiments can motivate clinical research, but they do not show that an oral supplement prevents Alzheimer’s disease or improves memory in people. Laboratory blood-brain-barrier findings in animals are not proof of effective human brain exposure.

Human fisetin research is emerging and remains limited. Registered studies have evaluated safety, pharmacokinetics, or preliminary outcomes in older adults; a trial registration is not evidence that a treatment works. Check the current registry status and published results before describing any trial as complete. There is no established clinical dose for Alzheimer’s prevention, and no guideline recommends fisetin for this purpose.

Practical next steps for memory concerns

Persistent memory change deserves a medical evaluation because sleep problems, depression, medication effects, hearing loss, thyroid disorders, and other treatable conditions can affect cognition. A clinician can assess symptoms, review medicines, and decide whether formal cognitive testing or specialist referral is appropriate. Do not delay that assessment to try an unproven supplement.

For brain health, established measures include cardiovascular risk management, physical activity, adequate sleep, social engagement, and treatment of hearing impairment where present. These steps do not guarantee prevention, but they have more clinical grounding than fisetin as an Alzheimer’s therapy. People using anticoagulants, antiplatelet drugs, cancer therapies, or multiple medicines should ask a clinician before using concentrated flavonoid supplements.

FAQ

Does fisetin treat Alzheimer’s disease? No proven clinical treatment effect has been established.

Should I use it to prevent dementia? Current evidence does not support that recommendation.

See the fisetin clinical-trials guide and fisetin safety profile.

Research: 2025 review of senolytic trials in Alzheimer’s disease; ClinicalTrials.gov study search.

Get the free Longevity Supplement Starter Guide

Sign up for the guide and occasional Stacking Years updates. The guide is available on the confirmation screen.